11.11.2014 • News

Platform Specialty Chemicals to Launch IPO

With three major acquisitions under its belt this year, Miami, Florida-based Platform Specialty Chemicals has launched a $350 million initial public offering to cover its past purchases and fund further growth.

The ipo, for which a share price has not yet been announced, will follow a $300 million offering in May of this year and a $651 million offering in October.

The Miami chemical firm's purchases during 2014 include three agrochemicals business, including Belgium's Agriphar for $300 million, Ireland-based Arysta Life Science for $3.5 billion and Chemtura AgroSolutions, a subsidiary of US chemical producer Chemtura for $1 billion.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read